PrescriptionDrugs.org

What to Expect When Starting Cyclobenzaprine

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.

Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.

Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.

See our Terms of Use and Editorial Policy.

Introduction

Cyclobenzaprine (brand name Flexeril) is the most commonly prescribed skeletal muscle relaxant in the United States [1]. It is structurally related to tricyclic antidepressants and works centrally in the brainstem to reduce muscle hyperactivity and spasm without directly affecting muscle function [2]. Cyclobenzaprine is prescribed for short-term relief (2-3 weeks) of muscle spasm associated with acute, painful musculoskeletal conditions such as back pain, neck pain, and fibromyalgia [1].

The medication is available in immediate-release tablets (5 mg, 7.5 mg, 10 mg) typically taken three times daily, and an extended-release capsule (15 mg, 30 mg) taken once daily [1]. Drowsiness is the most prominent effect — in clinical trials, approximately 38% of patients reported drowsiness, making it the most common side effect [2]. For some patients with pain-related sleep disturbance, this sedating property is actually beneficial.

This guide covers what to expect when starting cyclobenzaprine, including the onset of muscle relaxation, expected side effects, and important safety information. Cyclobenzaprine is intended for short-term use and is most effective when combined with rest, physical therapy, and other treatments for the underlying musculoskeletal condition. Always follow your prescriber's specific instructions.

Week-by-week timeline

First doseDrowsiness can be significant. Do not drive, operate machinery, or make important decisions after your first dose until you understand how the medication affects you [1].

Onset of effects

Cyclobenzaprine is well absorbed orally, with onset of effects within 1 hour and peak plasma levels at approximately 4 hours for immediate-release formulations [1]. The most noticeable initial effect is drowsiness, which can be significant — plan your first dose when you do not need to drive or perform tasks requiring alertness. Muscle relaxation effects begin within the first few hours. The half-life is 18 hours on average but can range from 8 to 37 hours, meaning effects persist well beyond a single dose [2].

  • Noticeable drowsiness within 1-2 hours
  • Muscle relaxation beginning within a few hours
  • Dry mouth (reported by 27% of patients)
  • Possible dizziness or lightheadedness
  • Mild blurred vision in some patients
Days 1-3If drowsiness is severe, ask your provider about reducing the dose. A 5 mg dose has been shown to be as effective as 10 mg with fewer side effects in many patients [3].

Adjusting to sedation

During the first few days, drowsiness is typically most pronounced as your body has not yet developed tolerance to cyclobenzaprine's sedating effects [1]. Starting at a lower dose (5 mg three times daily rather than 10 mg) and taking the larger portion of the daily dose at bedtime can help manage daytime sedation [2]. Dry mouth is persistent and is related to cyclobenzaprine's anticholinergic properties — the same mechanism responsible for its muscle relaxant effect [1].

  • Drowsiness gradually decreasing in intensity
  • Dry mouth continuing (manageable with water, sugar-free gum)
  • Muscle spasm and associated pain beginning to improve
  • Possible mild constipation from anticholinergic effects
  • Improved sleep quality due to sedating and muscle-relaxing effects
Days 4-7If you are not experiencing meaningful improvement by day 7, discuss with your provider — an alternative approach may be more appropriate [3].

Therapeutic benefit established

By the end of the first week, cyclobenzaprine's therapeutic effects are well-established. A systematic review found that cyclobenzaprine is most effective during the first 1-2 weeks of treatment [3]. The combination of muscle relaxation, reduced spasm, and improved sleep typically results in meaningful functional improvement. Drowsiness usually decreases as tolerance develops, though some sedation may persist throughout treatment [1][2].

  • Significant improvement in muscle spasm and associated pain
  • Drowsiness decreased from initial days
  • Dry mouth persisting but manageable
  • Improved mobility and function
  • Better sleep quality maintained
Weeks 2-3Do not extend use beyond the prescribed duration without medical guidance. Cyclobenzaprine is not intended for long-term use [1][2].

Completing treatment

Cyclobenzaprine is approved for short-term use only, typically 2-3 weeks [1]. Evidence does not support efficacy beyond this timeframe, and continued use increases the risk of anticholinergic side effects and potential dependence [2][3]. Your provider will plan discontinuation as your musculoskeletal condition improves. Physical therapy, stretching, and gradual return to activity should be ongoing during this period. Cyclobenzaprine can usually be stopped without tapering after a 2-3 week course [1].

  • Continued symptom improvement
  • Transition to non-medication management (PT, exercise)
  • Side effects well-tolerated or diminished
  • Provider planning discontinuation
  • Underlying condition typically improving

When to call your doctor

Contact your healthcare provider if you experience:

  • Rapid or irregular heartbeat, chest pain, or palpitations — cyclobenzaprine has cardiac effects similar to tricyclic antidepressants [1]
  • Signs of serotonin syndrome if taking with serotonergic medications: agitation, fever, muscle rigidity, rapid heartbeat, loss of coordination [1]
  • Severe allergic reaction: rash, hives, swelling of face or throat, difficulty breathing [1]
  • Difficulty urinating or inability to urinate — anticholinergic effect [2]
  • Severe drowsiness or confusion that does not improve with dose reduction
  • Yellowing of skin or eyes (jaundice) — rare hepatic effects have been reported [1]
  • Seizures — particularly in patients with seizure disorders [1]
  • Hallucinations or severe mental status changes [2]

Tips for getting started

Take cyclobenzaprine with water, with or without food. If daytime drowsiness is problematic, discuss with your provider about taking a smaller dose during the day and a larger dose at bedtime [2]. For example, some patients take 5 mg in the morning and afternoon and 10 mg at bedtime. The 5 mg dose has been shown in studies to provide comparable efficacy to 10 mg with significantly less drowsiness [3].

Manage dry mouth by sipping water frequently, using sugar-free gum or hard candies, and avoiding caffeine and alcohol, which worsen dehydration [1]. If constipation develops, increase fiber intake, drink plenty of fluids, and use a gentle stool softener. These anticholinergic side effects are dose-related and typically manageable.

Avoid alcohol completely while taking cyclobenzaprine — the combination significantly enhances CNS depression and can be dangerous [1]. Similarly, avoid other sedating medications (sleep aids, antihistamines, opioids, benzodiazepines) unless specifically prescribed by your provider who is aware of your cyclobenzaprine use. Use this medication as part of a comprehensive treatment plan that includes rest, physical therapy, and gradual return to activity — cyclobenzaprine alone is less effective than when combined with these approaches.

Frequently asked questions

More about Cyclobenzaprine

Cyclobenzaprine drug guideSide effects, dosage, interactions, and moreCyclobenzaprine vs GabapentinCompare these medicationsCyclobenzaprine vs TramadolCompare these medicationsCyclobenzaprine & TramadolInteraction detailsCyclobenzaprine & NifedipineInteraction details

References

  1. [Regulatory] Cyclobenzaprine Hydrochloride FDA Prescribing Information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017821s045lbl.pdf Accessed 2026-03-01.
  2. [Regulatory] Cyclobenzaprine. StatPearls [Internet]. National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK513362/ Accessed 2026-03-01.
  3. [Clinical] Browning R, Jackson JL, O'Malley PG. Cyclobenzaprine and back pain: a meta-analysis. Arch Intern Med. 2001;161(13):1613-1620. https://pubmed.ncbi.nlm.nih.gov/11434793/ Accessed 2026-03-01.

Written and fact-checked by PrescriptionDrugs.org Editorial Team

Last updated: